Solifenacin Vs Solifenacin+Duloxetine in Overactive Bladder Patients

Pratap Shankar

ISBN 10: 3659402923 / ISBN 13: 9783659402920

Verlag: LAP LAMBERT Academic Publishing Nov 2013, 2013

Beschreibung

This item is printed on demand - Print on Demand Titel. Neuware -So many drugs are available in medicine market with promise to treat the problem of Overactive Bladder (OAB). Among all the drugs Solifenacin and Duloxetine are mostly prescribed by the physicians to treat the above problem. In this work, we compared the treatments by Solifenacin alone versus Solifenacin with Duloxetine with respect to efficacy, better safety profile and positive impact on quality of life in patients of OAB. This was an open, parallel, prospective and randomized trial and was carried out in outpatient of the Department of Medicine, Eräs Lucknow Medical College & Hospital, Lucknow, India and Department of Urology of Chatrapati Shahuji Maharaj Medical university (CSMMU) Lucknow, India. This study may be a very good reference for the medical students, researchers, teachers, scientists as well as the patients and may also be helpful in eradication of the overactive bladder problem which cause the risk of bladder cancer.Books on Demand GmbH, Überseering 33, 22297 Hamburg 140 pp. Englisch.

Bestandsnummer des Verkäufers 9783659402920

Bibliografische Details

• Titel: Solifenacin Vs Solifenacin+Duloxetine in Overactive Bladder Patients
• Verlag: LAP LAMBERT Academic Publishing Nov 2013
• Erscheinungsjahr: 2013
• Sprache: Englisch
• ISBN-10: 3659402923
• ISBN-13: 9783659402920
• Einband: Taschenbuch
• Zustand: Neu

Über diesen Titel

Inhaltsangabe

So many drugs are available in medicine market with promise to treat the problem of Overactive Bladder (OAB). Among all the drugs Solifenacin and Duloxetine are mostly prescribed by the physicians to treat the above problem. In this work, we compared the treatments by Solifenacin alone versus Solifenacin with Duloxetine with respect to efficacy, better safety profile and positive impact on quality of life in patients of OAB. This was an open, parallel, prospective and randomized trial and was carried out in outpatient of the Department of Medicine, Era’s Lucknow Medical College & Hospital, Lucknow, India and Department of Urology of Chatrapati Shahuji Maharaj Medical university (CSMMU) Lucknow, India. This study may be a very good reference for the medical students, researchers, teachers, scientists as well as the patients and may also be helpful in eradication of the overactive bladder problem which cause the risk of bladder cancer.

Über die Autorin bzw. den Autor

ICMR-Senior Research Fellow & PhD Scholar,at King George’s Medical University, Lucknow; MSc Bioinformatics; SAS Certified Base Programmer; Certificate in Pharmaceutical Bioinformatics from Uppsala University, Sweden; PG Diploma Intellectual Property Rights from IGNOU Delhi with >40 Research Articles in National/International Journals.